Archana Narasanna

1.6k total citations
12 papers, 1.3k citations indexed

About

Archana Narasanna is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Archana Narasanna has authored 12 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Archana Narasanna's work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Archana Narasanna is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Archana Narasanna collaborates with scholars based in United States, Sweden and Switzerland. Archana Narasanna's co-authors include Carlos L. Arteaga, Shizhen Emily Wang, Marianela Pérez-Torres, Frederick Y. Wu, Senthil K. Muthuswamy, Bin Xiang, Seungchan Yang, Adi F. Gazdar, Graham Carpenter and Anindita Chakrabarty and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Archana Narasanna

12 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Archana Narasanna United States	9	817	576	368	362	181	12	1.3k
Maria Sundvall Finland	20	949 1.2×	1.2k 2.0×	364 1.0×	303 0.8×	289 1.6×	33	1.8k
Carmel Murone Australia	24	780 1.0×	610 1.1×	500 1.4×	511 1.4×	371 2.0×	51	1.8k
Peter D. Boasberg United States	21	1.1k 1.3×	761 1.3×	110 0.3×	170 0.5×	140 0.8×	44	1.7k
Dhara N. Amin United States	12	684 0.8×	782 1.4×	284 0.8×	177 0.5×	334 1.8×	19	1.2k
Christine Tan United States	10	487 0.6×	1.2k 2.0×	272 0.7×	143 0.4×	243 1.3×	17	1.9k
Hakim Bouterfa Germany	23	1.0k 1.3×	573 1.0×	491 1.3×	177 0.5×	228 1.3×	40	2.4k
Leah N. Klapper Israel	13	1.6k 1.9×	1.1k 1.9×	982 2.7×	312 0.9×	120 0.7×	17	2.2k
Paolo Fedi United States	10	753 0.9×	825 1.4×	454 1.2×	230 0.6×	59 0.3×	17	1.4k
Xiang-Dong Ji United States	5	754 0.9×	1.0k 1.8×	298 0.8×	282 0.8×	344 1.9×	5	1.8k
Y Yarden Israel	11	833 1.0×	1.0k 1.8×	474 1.3×	110 0.3×	145 0.8×	15	1.7k

Countries citing papers authored by Archana Narasanna

Since Specialization

Citations

This map shows the geographic impact of Archana Narasanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archana Narasanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archana Narasanna more than expected).

Fields of papers citing papers by Archana Narasanna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Archana Narasanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archana Narasanna. The network helps show where Archana Narasanna may publish in the future.

Co-authorship network of co-authors of Archana Narasanna

This figure shows the co-authorship network connecting the top 25 collaborators of Archana Narasanna. A scholar is included among the top collaborators of Archana Narasanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Archana Narasanna. Archana Narasanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rexer, Brent N., Ritwik Ghosh, Archana Narasanna, et al.. (2013). Human Breast Cancer Cells Harboring a Gatekeeper T798M Mutation in HER2 Overexpress EGFR Ligands and Are Sensitive to Dual Inhibition of EGFR and HER2. Clinical Cancer Research. 19(19). 5390–5401. 51 indexed citations

Ghosh, Ritwik, Archana Narasanna, Anindita Chakrabarty, Jeffrey A. Engelman, & Carlos L. Arteaga. (2012). Abstract 3: HER2 gene-amplified human breast cancer cells harboring a gatekeeper T768M mutation in HER2 overexpress EGFR ligands and are sensitive to dual therapeutic blockade of EGFR and HER2. Cancer Research. 72(8_Supplement). 3–3. 2 indexed citations

Ghosh, Ritwik, Archana Narasanna, Shizhen Emily Wang, et al.. (2011). Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers. Cancer Research. 71(5). 1871–1882. 171 indexed citations

Dave, Bhuvanesh, Ilenia Migliaccio, Maya Gutierrez, et al.. (2010). Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers. Journal of Clinical Oncology. 29(2). 166–173. 190 indexed citations

Miller, Todd W., Marianela Pérez-Torres, Archana Narasanna, et al.. (2009). Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer. Cancer Research. 69(10). 4192–4201. 141 indexed citations

Anderson, Alexander R.A., Mohamed Hassanein, Kevin M. Branch, et al.. (2009). Microenvironmental Independence Associated with Tumor Progression. Cancer Research. 69(22). 8797–8806. 46 indexed citations

Miller, Todd W., James T. Forbes, Chirayu Shah, et al.. (2009). Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells. Clinical Cancer Research. 15(23). 7266–7276. 99 indexed citations

Ghosh, Ritwik, et al.. (2009). Differential Signaling by ErbB Receptor (HER) Dimers: Implications for Response to Anti-HER2 Therapies in Breast Cancer.. Cancer Research. 69(24_Supplement). 705–705. 1 indexed citations

Wang, Shizhen Emily, et al.. (2007). Convergence of p53 and Transforming Growth Factor β (TGFβ) Signaling on Activating Expression of the Tumor Suppressor Gene maspin in Mammary Epithelial Cells. Journal of Biological Chemistry. 282(8). 5661–5669. 34 indexed citations

10.

Wang, Shizhen Emily, Archana Narasanna, Marianela Pérez-Torres, et al.. (2006). HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell. 10(1). 25–38. 374 indexed citations

11.

Wang, Shizhen Emily, Archana Narasanna, Marianela Pérez-Torres, et al.. (2006). HER2/neu (erbB2) kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGF receptors. 66. 343–344. 1 indexed citations

12.

Liu, Shumin, Ipe Ninan, Irina Antonova, et al.. (2004). α‐Synuclein produces a long‐lasting increase in neurotransmitter release. The EMBO Journal. 23(22). 4506–4516. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact